TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,669 | -50.0% | 41,348 | +48.6% | 0.00% | – |
| Q2 2023 | $691,098 | +189.9% | 27,822 | +75.5% | 0.00% | – |
| Q1 2023 | $238,369 | +92.7% | 15,849 | +51.6% | 0.00% | – |
| Q4 2022 | $123,683 | -56.6% | 10,455 | +21.9% | 0.00% | – |
| Q3 2021 | $285,000 | -40.9% | 8,574 | -31.0% | 0.00% | – |
| Q2 2021 | $482,000 | -8.4% | 12,421 | +13.9% | 0.00% | – |
| Q1 2021 | $526,000 | +49.9% | 10,908 | +61.5% | 0.00% | – |
| Q4 2020 | $351,000 | – | 6,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |